Note: Compounded drugs are not approved by the U.S. Food and Drug Administration (FDA) and may carry greater risks than FDA-approved treatments. In April 2025, the U.S. Food and Drug Administration ...

This article reviews the safety, efficacy, and regulatory concerns related to compounded semaglutide, with a focus on how health care providers can offer guidance and education to patients.

The FDA says shortages of GLP-1s are over, but many patients are still getting what are essentially copied medications. The market for drugs that treat obesity and help people lose weight is soaring.

A compounding pharmacy in Amherst is in trouble with the law after hiring a third-party company to help get prescriptions approved by insurers, including Medicare, with many of them allegedly being ...

Still life of Ozempic and Wegovy. Both are injectable prescription weight loss medicines. (Photo by: Michael Siluk/UCG/Universal Images Group via Getty Images) As demand surges for semaglutide ...

Note: Compounded drugs are not approved by the U.S. Food and Drug Administration (FDA) and may carry greater risks than FDA-approved treatments. The decision to take a brand-name or compounded GLP-1 ...

A $10,000 investment in SCHD at its 2011 launch, with dividends reinvested, would be worth approximately $49,000 today, reflecting a 12% annualized return and a dramatic boost from compounding. Yield ...

When Chris Spears' pharmacy didn't have the obesity drug his doctor prescribed in 2023, he found another option while scrolling on Facebook. His feed was full of advertisements for alternatives to the ...

With compounding, your money grows -- and the amount by which it grows also grows. Compounding can help you get to a million dollars -- or more. These 10 Stocks Could Mint the Next Wave of ...

TYLER, Texas (KLTV) -The future is uncertain for millions of people who use compounded drugs to lose weight. The Food and Drug Administration had determined there is no longer a shortage of drugs like ...

After May 22, compounding pharmacies can no longer make and sell semaglutide injections. They were initially allowed to because the FDA declared a shortage, but that period has ended. At Melrose ...